🚀 Day 21 of #ScaleBlack for #BlackHistoryMonth honors Dr. Del Smith & Tiffany Whitlow, the visionary founders of Acclinate, who are closing the health equity gap. 🚨 The pharmaceutical industry loses $10 billion every year due to a lack of diversity in clinical trials. But the real cost isn’t just financial- it’s measured in lives. And, for marginalized communities, exclusion from medical research means untested treatments, overlooked health risks, and a widening health equity gap that puts real human life on the line. Dr. Del Smith and Tiffany Whitlow realized there was too much at stake to stand still any longer. ⛑️ In 2017, they founded Acclinate, a tech-driven, trust-first platform that connects underrepresented communities with clinical trials—ensuring medical advancements reflect the people they’re meant to serve. 📊The Impact in Just a Few Years: 🔹 Raised $7 million in Series A funding, led by major healthcare players like Cencora Ventures and Labcorp 🔹 Built a community of 100,000+ engaged persons of color through their NOWINCLUDED platform 🔹 Achieved a 400% increase in pre-screened persons of color for clinical trials 📰 And the world is taking notice. The company has earned recognition from Inc. as a "Best in Business" for their digital health platform, while Fast Company and the Anthem Awards have honored the impact and potential on their work on the world stage. Acclinate's influence continues to grow in health equity and clinical trial diversity, validating both their innovative approach and vital mission—proving that true inclusion in medical research isn’t just necessary, it’s transformative. 🔥 On Day 21 of #ScaleBlack, we celebrate Dr. Del Smith and Tiffany Whitlow for building bridges of trust between overlooked communities and the medical field. You are appreciated. ➡️ Want to support their mission? Learn more at www.acclinate.com